MNG Laboratories

What MNG Laboratories does

MNG Laboratories is a specialized clinical diagnostic laboratory focused exclusively on genetic and biochemical testing for rare neurological disorders. The company operates as a wholly-owned operating division of Laboratory Corporation of America (Labcorp, NYSE: LH), functioning as Labcorp's neurogenetics specialty arm. Founded in 2001 and headquartered in Atlanta, MNG employs between 11 and 50 people and serves healthcare providers — primarily neurologists, geneticists, and genetic counselors — who order tests on behalf of patients navigating the "diagnostic odyssey" for rare neurological conditions.

The company's core technology platform is built around next-generation sequencing, offering three complementary modalities: MNGenome® whole genome sequencing, whole exome sequencing, and RNA sequencing. These are supplemented by phenotypically driven NGS panels that incorporate mtDNA testing, repeat expansion detection, and copy number analysis when clinically relevant. MNG differentiates its interpretation through a proprietary molecular systems approach that evaluates variants in the context of disease pathways rather than as isolated gene findings, combining molecular sequencing with biochemical testing for a comprehensive diagnostic workflow. Additional offerings include Familial Testing for hereditary risk assessment and a Data Reanalysis program that re-interprets existing patient data against updated gene-disease associations.

Commercially, MNG operates as a clinical diagnostic laboratory with a sales-led, healthcare-provider-driven go-to-market. Tests are ordered through providers and genetic counselors via the company's test ordering system, with revenue generated through insurance reimbursement, institutional billing, and direct patient billing under standard clinical laboratory fee schedules. The company leverages Labcorp's national logistics, payor contracts, and provider relationships for distribution, which materially extends its reach beyond what an independent esoteric lab of its size could achieve.

Name

MNG Laboratories

Legal name

MNG Laboratories

Website

https://mnglabs.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

MNG Laboratories is a specialty clinical diagnostic laboratory and wholly-owned Labcorp division providing whole genome, exome, and RNA sequencing for rare neurological disorders. It serves neurologists, geneticists, and genetic counselors seeking to resolve complex neurogenetic diagnoses.

Ownership category

akta.pro rank

Product category

Clinical Genetic Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

Keywords

• Neurogenetic diagnostic testing
• Clinical laboratory services
• Genomic sequencing services
• Rare disease diagnostics
• Molecular genetic testing

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Genetic Diagnostic Testing: MNG generates revenue through providing clinical genetic and biochemical testing services ordered by healthcare providers for patients with suspected neurogenetic disorders. Testing is billed to patients, insurance providers, or healthcare institutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

MNG Laboratories is a clinical diagnostic laboratory that delivers specialized neurogenetic testing services for rare neurological disorders. Its core offerings include whole genome sequencing (branded MNGenome®), whole exome sequencing, RNA sequencing, phenotypically driven next-generation sequencing panels with mtDNA, repeat expansion, and copy number analysis, biochemical testing, familial testing, and data reanalysis programs ordered by healthcare providers.

Product overview

MNG Laboratories offers a unified diagnostic platform specializing in analytics and diagnostic services for rare neurological disorders. The portfolio centers on three core sequencing products: MNGenome® (Whole Genome Sequencing), Whole Exome Sequencing, and RNA Sequencing, which are complemented by phenotypically driven next-generation sequencing panels. Additional services include Familial Testing and Data Reanalysis programs. MNG's proprietary approach evaluates genetic changes through the lens of molecular systems biology rather than isolated gene analysis, combining biochemical and molecular testing capabilities to help end the diagnostic odyssey for patients with rare neurological conditions.

Differentiator

Problem solved

Functional benefit

Brands

• MNGenome®: Proprietary whole genome sequencing service offered by MNG Laboratories for comprehensive genetic analysis.

Products and services

• MNGenome® (Whole Genome Sequencing) Comprehensive whole genome sequencing service analyzing the complete DNA sequence to identify genetic variants associated with rare neurological disorders, branded as MNGenome® and part of MNG's integrated neurogenetic testing platform for healthcare providers.
• Whole Exome Sequencing Targeted sequencing of the protein-coding exome to identify disease-causing mutations for patients with neurological conditions, ordered by healthcare providers as part of MNG's comprehensive genetic testing portfolio.
• RNA Sequencing Transcriptome analysis measuring gene expression levels and identifying RNA-based genetic changes, providing an additional analytical layer beyond DNA-based sequencing for neurogenetic diagnostic testing.
• Next-Generation Sequencing Panels Phenotypically driven next-generation sequencing panels for neurological disorders that include mtDNA testing, repeat expansion detection, and copy number analysis when clinically relevant, ordered by healthcare providers.
• Familial Testing Genetic testing service analyzing family members to identify inherited genetic variants and support diagnosis of familial neurological disorders, offered to patients and families through healthcare providers.
• Data Reanalysis Program that re-analyzes existing patient genetic data using updated methodologies and new gene-disease associations to provide updated diagnostic findings for patients who previously received inconclusive results.

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• LabcorpcoreOthersMNG Laboratories operates as a subsidiary of Labcorp (Laboratory Corporation of America Holdings), one of the largest clinical laboratory networks globally. MNG serves as Labcorp's specialized neurogenetics testing division, offering rare neurological disorder diagnostic services under the Labcorp corporate umbrella.

Recent moves5 records

Expansion highlights4 records

Direct peers

• Fulgent Genetics: Fulgent Genetics is a technology-driven genetic testing company offering WES, WGS, and specialty NGS panels across oncology, neurology, and rare disease. It competes with MNG in neurological panel design and pricing.
• PreventionGenetics: PreventionGenetics is a clinical DNA testing laboratory focused on hereditary disorders, offering WES and large gene panels across rare disease categories including neurology. Acquired by Exact Sciences, it competes head-on with MNG for rare neurogenetic test orders.
• GeneDx: GeneDx is a clinical genetic testing lab offering whole genome, exome, and specialty panels across rare disease and pediatric genetics. It is one of the closest direct competitors to MNG in rare disease neurogenetic testing and is now part of BioReference Laboratories.
• Centogene: Centogene is a rare disease diagnostics company providing WES, WGS, biochemical, and biomarker testing with particular depth in neurogenetics and lysosomal storage disorders. Comparable to MNG in clinical scope, patient focus, and rare disease specialty.
• Blueprint Genetics: Blueprint Genetics is a specialty clinical genetics lab offering NGS panels and WES/WGS for rare diseases including neurogenetic disorders. Now part of Quest Diagnostics, it directly competes with MNG in hereditary neurological testing.
• Invitae: Invitae is a large clinical genetic testing platform offering WGS, WES, and comprehensive neurological panels. It is now owned by Labcorp — MNG's parent — making it a direct competitor and corporate sister with overlapping capabilities in clinical genetics.
• Ambry Genetics: Ambry Genetics is a clinical genetics lab offering comprehensive NGS panels and exome sequencing across multiple specialties including neurology. Now part of Konica Minolta's Precision Medicine group, it competes with MNG on neurological hereditary panels.

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory networks in the US, offering a broad menu including genetic and neurological testing. As a broad incumbent and parent of Blueprint Genetics, it competes with MNG across clinical specialty genetics.
• ARUP Laboratories: ARUP Laboratories is a large nonprofit reference laboratory affiliated with the University of Utah offering a broad menu of esoteric testing including molecular genetics and neurogenetic panels. It is a broader incumbent whose neurogenetic menu overlaps with MNG's offerings.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory arm of Mayo Clinic offering a broad esoteric test menu including neurogenetic and rare disease testing. As a large academic reference lab, it provides an alternative referral channel to MNG for complex neurogenetic cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/LabCorp
• LinkedInlinkedin.com/company/mng-laboratories

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MNG Laboratories